GluA3 is X-chromosome linked, and its mutations contribute to multiple disorders including epilepsy, intellectual disability, aggression and schizophrenia2,21–24, rendering this AMPAR subunit a central but structurally poorly defined drug target. This evidence concerns the gene GRIA3 and epilepsy.